Topic Archives: Rhythm Pharmaceuticals (RYTM)

President Trump’s “germophobia” and longstanding reluctance to shake hands or hug people hasn’t saved him from exposure to the coronavirus, we learn this morning — both the President and First Lady have tested positive, following the announcement yesterday that Hope Hicks was going into quarantine after a positive test — but perhaps it will help […]

This article was originally posted on August 27, when we first saw these ads circulating… apparently lots of folks missed it, and the ads are running hot and heavy again, so we’re re-posting it here to help answer a flood of new reader questions. The stock teased has popped 40-50% or so on the Stansberry […]

Comments

  • Avatar

    You missed this one bravobilly, wake up! (I was wrong). Mr. Lashmet sees RYTM in the wings waiting for the stage to cle...

  • Avatar

    I don't think Lashmet mentioned RYTM this time. It was a COVID related deal in the beginning, obesity being the conditi...

  • Avatar

    I've been burned by two of his picks in the past, Rhythm Pharmaceuticals (RYTM) and Esperion Therapeutics (ESPR). Both h...

  • Travis Johnson, Stock Gumshoe

    They reported some results yesterday -- a third of people in the trial experienced weight loss of 5% in three months for...

  • Avatar

    BTW, I like RYTM very much because in America every where I look, there are too many fat, yes fat people . Even Uncle Sa...

  • Avatar

    Yes, very happy I decided to hold my position on RYTM since September despite the stock falling to 20.87 only as recentl...

  • Avatar

    Travis, I bought some shares of this RYTM after I firs read this article back in Sept. 2020, on average I paid about $...

  • Avatar

    RYTM I t is a BIG winner!...

  • Travis Johnson, Stock Gumshoe

    If you mean the drug EFX, I believe that’s being developed by Akero Therapeutics. I’m still sure this tease was a...

  • Avatar

    Are we sure that RYTM is the stock they were referring to? There is another company EFX Pharmaceutical that seems to f...

  • Avatar

    Yes Stansberry's newsletters often drive markets. This morning they advised selling SII after it hit a trailing stop an...

  • Avatar

    I bought RYTM in early Sept and now its way down 28%, so I am past my trailing stop. Normally I would sell all or part o...

  • Avatar

    A couple of days ago I received from Stansberry in the mail a Very Fancy promotional package stating "You're one of onl...

  • Avatar

    Cartero, As Travis, elesido, ell and other Gumshoe folks have reported, RYTM addresses ultra-rare pediatric obes...

  • Avatar

    If you go on their website and read through the details about this drug, it says it specifically targets a small group, ...

  • Avatar

    I can attest to Rythm (RYTM) being correct and available on Nasdaq. I've owned it for several months now since Ventures ...

  • Avatar

    I have to correct my last message, and I can confirm that RYTM is correct. They have also just raised the buy-up price o...

  • Avatar

    What a "story stock"! This could be huge. Stansberry sent out an email Sunday morning, 8.30.20, promoting this Obe...

  • Avatar

    You say it's not RYTM; Travis says it is RYTM. I have never heard of you before; I have a good history with Travis. Unt...

  • Avatar

    Ascentage is developing anticancer drugs, and their first US trial (Phase Ib/II) was just approved. It can't be Ascentag...

  • Avatar

    Thanks for the confirmation, Travis. I started researching the tease, narrowed it down to RYTM, then looked to your feed...

  • Avatar

    That's interesting I wonder what caused the caused the RYTM price to go from $19 to pretty much $27. Is it the gumshoe e...

  • Avatar

    I like your analysis Travis, but I am a Stansberry Alliance member and I can tell you it is not RYTM. It is a VERY TINY...

  • Avatar

    I say it is Rhythm Pharmaceuticals RYTM. I have seen his video at Dailywealth.com. Go to to Biospace.com and enter Rh...

  • Avatar

    Injections are nasty indeed. This is why I bought a few shares of Oramed (ORMP) which seems to be in final testing stag...

  • Avatar

    Thanks to Author/Editor: Dave Lashmet for reading and going through this long and tedious Stansberry stock tip/newslette...

  • Avatar
  • Avatar
  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info